Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Koki Morishita
Institution:
Teine Keijinkai Hospital
Observed institutions:
Teine Keijinkai Hospital,
National Cancer Center Hospital East
ORCID:
0009-0006-4637-7606
Observed ORCID:
0009-0006-4637-7606
OpenAlex ID:
A5113894192
Non-acute effects of passive heating interventions on cardiometabolic risk and vascular health: systematic review and meta-analysis of randomized controlled trials
2025
·
Rikuta Hamaya
, Yuki Joyama
, et al.
·
American Journal of Preventive Cardiology
·
6
Impact of Hemoglobin Level, White Blood Cell Count, Renal Dysfunction, and Staphylococcus as the Causative Organism on Prediction of In-Hospital Mortality from Infective Endocarditis: A Single-Center Retrospective Cohort Study
2024
·
Masamichi Koike
, Takahiro Doi
, et al.
·
International Heart Journal
·
4
PDF
Cost-effectiveness of systematic chemotherapy for metastatic pancreatic cancer: a retrospective study using Japanese clinical data
2025
·
Akira Shinohara
, Yuki Takumoto
, et al.
·
Scientific Reports
·
1
PDF
Prognostic effect of liver fibrosis marker in systolic heart failure with cardiac nerve denervation and renal dysfunction
2026
·
Ryosuke Hatano
, Takahiro Doi
, et al.
·
Journal of Cardiology
Clinical effect of three-dimensional left ventricular mechanical dyssynchrony and cardiac sympathetic denervation in systolic heart failure risk-stratified by left ventricular ejection fraction and QRS duration
2025
·
Takahiro Doi
, Koki Morishita
, et al.
·
EJNMMI Research
PDF
Recurrent Vomiting due to Severe Hyponatremic-Hypertensive Syndrome in an Elderly Patient
2025
·
Koki Morishita
, Kaito Nakamura
, et al.
·
Internal Medicine
Usefulness of FilmArray® in early diagnosis and therapeutic intervention of influenza myocarditis
2024
·
Koki Morishita
, Takahiro Doi
, et al.
PDF
Benefits of measuring urinary protein/creatinine ratio in lenvatinib treatment for unresectable hepatocellular carcinoma.
2023
·
Koki Morishita
, Hidetaka Suzuki
, et al.
·
Journal of Clinical Oncology
Comparison of the frequency of adverse events requiring interventions determined by telephone follow up in hepatocellular carcinoma patients treated with sorafenib and lenvatinib.
2020
·
Koki Morishita
, Hidetaka Suzuki
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
9
Citation count:
11
H-index:
2
I10-index:
Year
Topic
Type